Li Xin, Liu Minghui, Zhao Qingchun, Liu Renwang, Zhang Hongbing, Dong Ming, Xu Song, Zhao Honglin, Wei Sen, Song Zuoqing, Chen Gang, Chen Jun
Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
Zhongguo Fei Ai Za Zhi. 2020 Mar 20;23(3):133-135. doi: 10.3779/j.issn.1009-3419.2020.03.01. Epub 2020 Feb 20.
In December 2019, China diagnosed the first patient with 2019 novel coronavirus disease (COVID-19), and the following development of the epidemic had a huge impact on China and the whole world. For patients with lung occupying lesions, the whole process of diagnosis and treatment can not be carried out as usual due to the epidemic. For thoracic surgeons, the timing of surgical intervention should be very carefully considered. All thoracic surgeons in China should work together to develop the proper procedures for the diagnosis and treatment in this special situation, and continuously update the recommendations based on epidemic changes and further understanding of COVID-19. Here, we only offer some preliminary suggestions based on our own knowledge for further reference and discussion.
2019年12月，中国确诊首例新型冠状病毒肺炎（COVID-19）患者，随后疫情的发展对中国乃至全球都产生了巨大影响。对于肺部占位性病变患者，由于疫情，整个诊疗过程无法像往常一样进行。对于胸外科医生而言，手术干预的时机需要非常谨慎地考虑。中国所有胸外科医生应共同努力，制定出在这种特殊情况下的诊疗规范，并根据疫情变化以及对COVID-19的进一步认识不断更新建议。在此，我们仅基于自身知识提供一些初步建议，以供进一步参考和讨论。
